Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA058576-04
Application #
2099255
Study Section
Experimental Immunology Study Section (EI)
Project Start
1993-04-01
Project End
1997-12-31
Budget Start
1996-01-01
Budget End
1996-12-31
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Bensinger, W I; Maloney, D; Storb, R (2001) Allogeneic hematopoietic cell transplantation for multiple myeloma. Semin Hematol 38:243-9
Bensinger, W I; Storb, R (2001) Allogeneic peripheral blood stem cell transplantation. Rev Clin Exp Hematol 5:67-86
Fefer, A; Robinson, N; Benyunes, M C et al. (1997) Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies. Cancer J Sci Am 3 Suppl 1:S48-53
Fefer, A (1997) Interleukin-2 in the treatment of hematologic malignancies. Cancer J Sci Am 3 Suppl 1:S35-6
Lindgren, C G; Thompson, J A; Robinson, N et al. (1997) Interleukin-12 induced cytolytic activity in lymphocytes from recipients of autologous and allogeneic stem cell transplants. Bone Marrow Transplant 19:867-73
Robinson, N; Benyunes, M C; Thompson, J A et al. (1997) Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study. Bone Marrow Transplant 19:435-42
Benyunes, M C; Higuchi, C; York, A et al. (1995) Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial. Bone Marrow Transplant 16:283-8